Literature DB >> 17224849

The diagnosis and treatment of HIV-infected children in China: challenges and opportunities.

Fujie Zhang1, Maria C Au, Paul D Bouey, Yan Zhao, Zhihuan Jennifer Huang, Zhihui Dou, Zaicun Li, Jessica Haberer, Ray Y Chen, Lan Yu.   

Abstract

BACKGROUND: HIV-infected children in China have not been well studied. This national survey describes the demographic characteristics and the associated diagnostic and antiretroviral treatment (ART) efforts directed toward surviving HIV-infected children.
METHODS: A cross-sectional study was conducted in the 6 provinces with the highest HIV prevalence: 4 former plasma donation (FPD) provinces and 2 intravenous drug use (IDU) provinces. A survey on demographics and treatment-related issues was distributed to the parents or guardians of all living HIV-infected children identified through the national case reporting system. Descriptive and bivariate analyses were performed on completed surveys.
RESULTS: Six hundred ninety-two (62.4%) of the total 1108 surveys were returned, and 650 were eligible for analysis. The average age in FPD provinces (mean +/- SD: 8.1 +/- 3.2 years) was significantly older than in IDU provinces (mean +/- SD: 5.4 +/- 2.2 years; P < 0.001). The average lag time from the probable date of transmission to a diagnosis for patients with mother-to-child transmission (MTCT) was 6.7 +/- 3.1 years in the FPD provinces and 4.7 +/- 1.9 years in the IDU provinces (P < 0.001). On the basis of the CD4 cell count or World Health Organization staging, 29.8% (144 of 484) of children from all 6 provinces who were not on ART needed it.
CONCLUSIONS: This first national pediatric survey indicates that the age and time required for diagnosis were greater in HIV-infected children from FPD provinces compared with those from IDU provinces. In addition, this survey highlights the prolonged delay in the diagnosis and initiation of ART for children in China. Aggressive efforts to identify HIV-positive pregnant women, scale up prevention of MTCT activities, and expand early diagnosis and treatment are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17224849     DOI: 10.1097/QAI.0b013e31803133ac

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  Impact of Single Nucleotide Polymorphisms on Plasma Concentrations of Efavirenz and Lopinavir/Ritonavir in Chinese Children Infected with the Human Immunodeficiency Virus.

Authors:  Xia Liu; Qing Ma; Yan Zhao; Weiwei Mu; Xin Sun; Yuewu Cheng; Huiping Zhang; Ye Ma; Fujie Zhang
Journal:  Pharmacotherapy       Date:  2017-09-03       Impact factor: 4.705

2.  Attitudes toward antiretroviral therapy and complementary and alternative medicine in Chinese patients infected with HIV.

Authors:  Wei-Ti Chen; Cheng-Shi Shiu; Jane Simoni; Karen Fredriksen-Goldsen; Fujie Zhang; Helene Starks; Hongxin Zhao
Journal:  J Assoc Nurses AIDS Care       Date:  2009 May-Jun       Impact factor: 1.354

3.  Knowledge, attitudes, perceived vulnerability of Chinese nurses and their preferences for caring for HIV-positive individuals: a cross-sectional survey.

Authors:  Wei-Ti Chen; Mei Han
Journal:  J Clin Nurs       Date:  2010-11       Impact factor: 3.036

4.  Cohort profile: the Chinese national free antiretroviral treatment cohort.

Authors:  Ye Ma; Fujie Zhang; Yan Zhao; Chunpeng Zang; Decai Zhao; Zhihui Dou; Lan Yu; Hua Fang; Timothy Y Zhu; Ray Y Chen
Journal:  Int J Epidemiol       Date:  2009-06-25       Impact factor: 7.196

5.  Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.

Authors:  Minqi Luo; Huan Liu; Ke Zhuang; Li Liu; Bo Su; Rongrong Yang; Po Tien; Linqi Zhang; Xien Gui; Zhiwei Chen
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

6.  Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009.

Authors:  Shuntai Zhou; Yan Zhao; Yun He; Huiqin Li; Marc Bulterys; Xin Sun; Zhihui Dou; Matthew Robinson; Fujie Zhang
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

Review 7.  Prevention of mother-to-child HIV transmission cascade in China: a systematic review and meta-analysis.

Authors:  Huan Zeng; Eric P F Chow; Yong Zhao; Yang Wang; Maozhi Tang; Leyu Li; Xue Tang; Xi Liu; Yi Zhong; Ailing Wang; Ying-Ru Lo; Lei Zhang
Journal:  Sex Transm Infect       Date:  2015-05-02       Impact factor: 3.519

8.  A comparison between antenatal care quality in public and private sector in rural Hebei, China.

Authors:  Li Chen; Yaohua Dai; Yanfeng Zhang; Qiong Wu; Diana Rudan; Vanja Saftić; Michelle H M M T van Velthoven; Jianqiang Su; Zangwen Tan; Robert W Scherpbier
Journal:  Croat Med J       Date:  2013-04       Impact factor: 1.351

9.  Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.

Authors:  Ka-Wai Cheung; Qiaoli Peng; Liufen He; Kanru Cai; Qiang Jiang; Boping Zhou; Sabrina Wai-Chi To; Wing-Cheong Yam; Li Liu; Zhiwei Chen; Hui Wang
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

10.  We don't dare to tell her … we don't know where to begin: Disclosure experiences and challenges among adolescents living with HIV and their caregivers in China.

Authors:  Mary Bachman DeSilva; Nicole Penwill; Lora Sabin; Allen L Gifford; Zhong Li; Zhang Fujie; Mu Weiwei; Li Yongzhen; Lu Hongyan; Zeng Xuemei; Yiyao Barnoon; Christopher J Gill; Rachael Bonawitz
Journal:  Int J Pediatr Adolesc Med       Date:  2018-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.